InforCapital

M&A Transaction Database

Healthcare Healthtech & Medtech M&A Transactions

Mergers and acquisitions in the Healthcare Healthtech & Medtech sector.

Filters

58 shown

Date:Apr 6, 2026
Technimark Acquires Rage Custom Plastics for Healthcare Growth

Technimark strengthens its healthcare manufacturing by acquiring Rage Custom Plastics, boosting its US footprint and blow molding capabilities. Backed by Oak Hill Capital and Pritzker Private Capital.

Acquirer:Technimark
Deal Value:n/a
Country:🇺🇸
Date:Apr 6, 2026
Prestige Buys $1B OTC Brands from Foundation

Prestige Consumer Healthcare acquires a $1.045B OTC portfolio including Breathe Right from Foundation Consumer Healthcare, sharpening Foundation's focus on Women's Health.

Acquirer:Prestige Consumer Healthcare
Deal Value:n/a
Country:🇺🇸
Date:Apr 5, 2026
Guardant Health Acquires MetaSight Diagnostics for $150M

Guardant Health boosts liquid biopsy tech with MetaSight Diagnostics acquisition. Deal valued up to $150M, expanding early cancer detection and disease identification.

Acquirer:Guardant Health
Deal Value:n/a
Country:🇮🇱 🇺🇸
Date:Apr 5, 2026
HouseWorks Acquires ACE, Expands New England Home Care

HouseWorks Holdings, backed by InTandem Capital Partners, acquires A Caring Experience Nursing Services, enhancing its home care services in New England.

Acquirer:HouseWorks Holdings
Deal Value:n/a
Country:🇺🇸
Date:Apr 5, 2026

Harrison Street Asset Management

Harrison Street Buys Connecticut Senior Housing Assets

Harrison Street Asset Management expands senior housing portfolio in Connecticut, partnering with LCB Senior Living in a strategic move for the growing sector.

Acquirer:
Deal Value:n/a
Country:🇺🇸
Date:Apr 4, 2026
Infosys Acquires Optimum Healthcare IT for $465M

Infosys strengthens U.S. healthcare market presence with the $465M acquisition of Optimum Healthcare IT, enhancing digital transformation and consulting services.

Acquirer:Infosys
Deal Value:n/a
Country:🇺🇸
Date:Apr 3, 2026
Shionogi Acquires RADICAVA for $2.5B, Eyes Rare Disease Growth

Shionogi & Co., Ltd. invests $2.5 billion in RADICAVA, building a rare disease platform and enhancing its ALS treatment offerings.

Acquirer:Shionogi &
Deal Value:n/a
Country:🇯🇵
Date:Apr 3, 2026
WTWH Media Acquires HealthLeaders to Expand Healthcare Platform

WTWH Media strengthens its healthcare media and events presence with the acquisition of HealthLeaders, aiming to connect more industry leaders and insights.

Acquirer:WTWH Media
Deal Value:n/a
Country:🇺🇸
Date:Apr 3, 2026
SV Health Investors Acquires EpiVax Immunogenicity CRO

SV Health Investors secures EpiVax, a key player in immunogenicity risk assessment for pharma and biotech, enhancing drug development efficiency.

Deal Value:n/a
Country:🇺🇸
Date:Apr 3, 2026
Gyde Acquires Avid Health to Expand Medicare Market Reach

AI-native brokerage platform Gyde acquires Medicare agency Avid Health, accelerating its expansion and modernization of insurance distribution.

Acquirer:Gyde
Deal Value:n/a
Country:🇺🇸
Date:Apr 3, 2026
Sycamore Targets $4B Profit at Walgreens

Sycamore Partners aims to double Walgreens' profitability to $4B following its $10B acquisition, implementing operational and cost-saving strategies.

Deal Value:n/a
Country:🇺🇸
Date:Apr 3, 2026
Oury Medical Acquires Cefimeca, Bolsters Medical Device Portfolio

Oury Medical expands orthopedic and spinal offerings with Cefimeca acquisition, backed by TAG Partners and ISALT. Enhances manufacturing and market reach.

Acquirer:Oury Medical
Deal Value:n/a
Country:🇫🇷
Date:Apr 2, 2026
Lupin Acquires European Eye Care Firm VISUfarma

Global pharma major Lupin Limited completes acquisition of VISUfarma B.V., significantly expanding its ophthalmology portfolio and European market reach.

Acquirer:Lupin
Deal Value:n/a
Country:🇮🇹 🇬🇧 🇪🇸 🇩🇪 🇫🇷
Date:Apr 1, 2026

Cyclerion Therapeutics

Korsana Biosciences Merges with Cyclerion, Secures $380M

Korsana Biosciences and Cyclerion Therapeutics merge, backed by $380M financing. Focus on advancing Alzheimer's drug KRSA-028 and neurodegenerative pipeline.

Acquirer:
Deal Value:n/a
Country:🇺🇸
Date:Apr 1, 2026

Axsome Therapeutics

Axsome Therapeutics Acquires CNS Drug Candidate from Takeda

Axsome Therapeutics secures global rights to balipodect, a novel PDE10A inhibitor, aiming to enhance its neuroscience portfolio for neuropsychiatric conditions.

Acquirer:
Deal Value:n/a
Country:🇺🇸
Date:Apr 1, 2026
CapVest Acquires STADA Arzneimittel AG for €10 Billion

CapVest Partners completes €10 billion acquisition of STADA Arzneimittel AG, a leading global healthcare company, from Bain Capital and Cinven.

Deal Value:n/a
Country:🇩🇪
Date:Apr 1, 2026

Two Great Helms Stock

Two Great Helms Ownership Shift Amid Financial Headwinds

Iconic Chinese herbal toothpaste maker Two Great Helms faces a controlling shareholder change amid declining profits. Potential acquirers identified.

Acquirer:Guangxi Health and Wellness Group
Deal Value:n/a
Country:🇨🇳
Date:Apr 1, 2026

SEMEIA

SEMEIA, HEALABS Merge: France's Telemonitoring Leader

SEMEIA and HEALABS unite to create a dominant French digital health group, enhancing remote patient care for over 35,000 individuals.

Acquirer:
Deal Value:n/a
Country:🇫🇷
Date:Apr 1, 2026
Danone Acquires Huel to Boost Protein Portfolio

Danone strengthens its health and nutrition offerings by acquiring Huel, a leading UK-based protein and meal replacement brand. Learn more about the deal.

Acquirer:Danone
Deal Value:n/a
Country:🇬🇧 🇫🇷
Date:Mar 31, 2026
IKS Health Acquires ThinkDTM for Patient Access Tech

IKS Health strategically acquires ThinkDTM, bolstering patient access with AI and product design expertise. Learn how this enhances healthcare delivery.

Acquirer:IKS Health
Deal Value:n/a
Country:🇺🇸
Date:Mar 31, 2026
DaySmart Software Acquires Slick, Expands Global Beauty Tech

DaySmart Software enhances its international footprint and beauty/wellness software offerings through the strategic acquisition of Slick Software.

Acquirer:DaySmart Software
Deal Value:n/a
Country:🇺🇸
Date:Mar 31, 2026
Biogen Acquires Apellis for $5.6B, Boosting Rare Disease Portfolio

Biogen secures Apellis Pharmaceuticals in a $5.6 billion deal, enhancing its immunology and rare disease offerings with two approved therapies and expanding nephrology reach.

Acquirer:Biogen
Deal Value:n/a
Country:🇺🇸
Date:Mar 31, 2026
Lilly Acquires Centessa for $6.3B to Boost Sleep Disorder Pipeline

Eli Lilly and Company announces $6.3 billion acquisition of Centessa Pharmaceuticals, expanding its neuroscience focus on sleep-wake disorder treatments.

Acquirer:Eli Lilly and
Deal Value:n/a
Country:🇺🇸
Date:Mar 31, 2026

Playlist

Playlist, EGYM Merge in $7.5B Fitness Industry Consolidation

Playlist and EGYM unite in a $7.5 billion merger, forming a global fitness and wellness leader with integrated technology and extensive market reach.

Acquirer:
Deal Value:n/a
Country:🇺🇸
Date:Mar 31, 2026
Biogen Acquires Apellis for $5.6B in Rare Disease Push

Biogen Inc. secures Apellis Pharmaceuticals for $5.6 billion, enhancing its rare disease and immunology portfolio with key therapies for kidney conditions and macular degeneration.

Acquirer:Biogen
Deal Value:n/a
Country:🇺🇸
Date:Mar 31, 2026

CareHub

CareHub Expands Italian Diagnostics Network with Acquisitions

CareHub, supported by Quadrivio Group, grows its Italian diagnostic clinics through multiple acquisitions, aiming for significant revenue growth and market leadership.

Acquirer:
Deal Value:n/a
Country:🇮🇹
Date:Mar 31, 2026
Creas Invests in Spanish Adolescent Mental Health Firm

Creas Impacto II backs Desconect@'s expansion in adolescent mental health services, addressing digital addiction and well-being challenges in Spain.

Deal Value:n/a
Country:🇪🇸
Date:Mar 31, 2026
Palladium Equity Acquires DME Express in Healthcare Deal

Palladium Equity Partners to acquire DME Express, a leading hospice medical equipment provider. Learn about this strategic healthcare services acquisition.

Deal Value:n/a
Country:🇺🇸
Date:Mar 31, 2026

Viventium

Viventium Acquires Perks4Care to Boost Home Care Tech

LLR Partners-backed Viventium integrates Perks4Care's caregiver rewards platform, strengthening its position in the expanding home healthcare technology sector.

Acquirer:
Deal Value:n/a
Country:🇺🇸
Date:Mar 30, 2026
Columna Capital Eyes Evidenze Acquisition for €150M

Columna Capital in exclusive talks to buy Evidenze for €150M. Learn about the deal, Evidenze's services, and market implications for healthcare PE.

Deal Value:n/a
Country:🇪🇸
Date:Mar 30, 2026
CVC Eyes Recordati Take-Private at $12.6B

CVC Capital Partners submits a $12.6B non-binding offer to acquire full control of Italian pharmaceutical firm Recordati, signaling a major European healthcare buyout.

Deal Value:n/a
Country:🇮🇹
Date:Mar 29, 2026
Collectly Acquires Pledge Health for Revenue Cycle Automation

Collectly enhances its AI patient financial platform by acquiring Pledge Health, aiming to automate the entire healthcare revenue cycle from pre-service to payment.

Acquirer:Collectly
Deal Value:n/a
Country:🇺🇸
Date:Mar 28, 2026
Herbalife Acquires Ronaldo-Backed Bioniq for $55M

Wellness giant Herbalife acquires personalized nutrition startup Bioniq for up to $150M, enhancing its data-driven health platform.

Acquirer:Herbalife
Deal Value:n/a
Country:🇺🇸 🇬🇧
Date:Mar 28, 2026
Gilead Buys Ouro Medicines for $1.7B to Boost Autoimmune Therapies

Gilead Sciences acquires Ouro Medicines for $1.675B upfront, plus milestones, to advance its autoimmune T cell therapy pipeline.

Acquirer:Gilead Sciences
Deal Value:n/a
Country:🇺🇸
Date:Mar 28, 2026
Cerebral Acquires Inflow to Expand Digital Health Services

Cerebral enhances its digital health offerings by acquiring Inflow, a specialized ADHD support app, to provide continuous, personalized patient care.

Acquirer:Cerebral
Deal Value:n/a
Country:🇺🇸
Date:Mar 28, 2026
Vimian Group Acquires Italian Veterinary Diagnostics Firm

Vimian Group AB enhances its companion animal diagnostics capabilities by acquiring I-Vet and Biofleet in Italy, a strategic move in a growing market.

Acquirer:Vimian Group
Deal Value:n/a
Country:🇮🇹
Date:Mar 27, 2026
Herbalife Acquires Bioniq for Personalized Nutrition

Herbalife boosts its data-driven wellness strategy by acquiring Bioniq for up to $150M, enhancing personalized nutrition offerings globally.

Acquirer:Herbalife
Deal Value:n/a
Country:🇬🇧 🇺🇸
Date:Mar 27, 2026
CVC Capital Partners Eyes Recordati Take-Private for €10.9B

CVC Capital Partners submits a €10.9 billion non-binding offer to acquire Recordati S.p.A., aiming to take the Italian pharmaceutical company private.

Deal Value:n/a
Country:🇮🇹
Date:Mar 26, 2026

Sensio

Sensio Acquires ISECO, Bolstering European Care Tech Presence

Nordic Capital-backed Sensio expands its European footprint by acquiring Spanish care tech leader ISECO, enhancing its market position and service offerings.

Acquirer:
Deal Value:n/a
Country:🇪🇸 🇵🇹 🇳🇴 🇬🇧
Date:Mar 25, 2026
Danone Acquires Huel for $1.15 Billion

Danone strengthens its functional nutrition portfolio by acquiring Huel for $1.15 billion, tapping into the booming market for convenient, plant-based meal solutions.

Acquirer:Danone
Deal Value:n/a
Country:🇬🇧 🇺🇸 🇫🇷

Never Miss a Deal

Get weekly investment intelligence. Free forever.